The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers

July 27, 2023 updated by: Dea Haagensen Kofod, Bispebjerg Hospital

The Use of Self-reported Symptoms as a Proxy for Acute Organophosphate Poisoning Among Nepali Farmers: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

The purpose of this study is to evaluate self-reported symptoms as a proxy for acute organophosphate poisoning by examining self-reported acute organophosphate poisoning symptoms and PchE activity in response to occupational acute organophosphate exposure among farmers in Nepal.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • male
  • minimum age 18 years
  • hand pressured backpack sprayer usage
  • used to spray with moderately to extremely hazardous pesticides according to the World Health Organization's (WHO) Pesticide Hazard Classification

Exclusion Criteria:

  • usual personal protective equipment use (respirator/mask with particulate filter, face shield, googles, gloves, boots, plastic poncho)
  • unwilling to stay pesticide-free seven days prior to each of the two spray sessions
  • medical conditions interfering with PchE activity (liver disease, acute infection, chronic malnutrition, heart attack, cancer, obstructive jaundice, inflammation caused by various diseases, or use of pyridostigmine drugs)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group A
Initial spray session: organophosphate. Crossover spray session: placebo
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other Names:
  • Biopesticide
Other: Group B
Initial spray session: placebo. Crossover spray session: organophosphate
Chlorpyrifos 50% plus cypermethrin 5%, WHO Class II: Moderately hazardous
Multineem, WHO Class U: Unlikely to present acute hazard in normal use
Other Names:
  • Biopesticide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in self-reported acute organophosphate poisoning symptoms from baseline to follow up
Time Frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
Obtained using a structured questionnaire interview. The definition of symptoms was based on WHO's standardized list of clinical presentations of acute organophosphate poisoning.
Obtained just before (baseline) and 30 minutes after (baseline) each spray session
Change in Plasma Cholinesterase (PchE) activity from baseline to follow up
Time Frame: Obtained just before (baseline) and 30 minutes after (baseline) each spray session
PchE activity was measured with a blood test using a Test-mate Che Cholinesterase System (Model 400) with a PchE Plasma Cholinesterase Assay Kit (Model 470).
Obtained just before (baseline) and 30 minutes after (baseline) each spray session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Dea H. Kofod, MB, Department of Occupational and Environmental Medicine, Bispebjerg Frederiksberg Hospital, University of Copenhagen

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

July 14, 2016

First Submitted That Met QC Criteria

July 17, 2016

First Posted (Estimated)

July 20, 2016

Study Record Updates

Last Update Posted (Actual)

July 28, 2023

Last Update Submitted That Met QC Criteria

July 27, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 12205-01-57-02

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Organophosphate Poisoning

Subscribe